Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3520

1.

Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.

Rui S, Yan J, Zhang H, Wang Z, Zhou W.

Medicine (Baltimore). 2017 Jul;96(30):e7608. doi: 10.1097/MD.0000000000007608.

2.

Liver transplantation using the otherwise-discarded partial liver resection graft with hepatic benign tumor: Analysis of a preliminary experience on 15 consecutive cases.

Li G, Mu X, Huang X, Qian X, Qin J, Tan Z, Zhang W, Xu X, Tan S, Zhu Z, Li W, Wang X, Wang X, Sun B.

Medicine (Baltimore). 2017 Jul;96(29):e7295. doi: 10.1097/MD.0000000000007295.

3.

A nomogram prediction of postoperative surgical site infections in patients with perihilar cholangiocarcinoma.

Li L, Ding J, Han J, Wu H.

Medicine (Baltimore). 2017 Jun;96(25):e7198. doi: 10.1097/MD.0000000000007198.

4.

Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.

Wakiyama S, Matsumoto M, Haruki K, Gocho T, Sakamoto T, Shiba H, Futagawa Y, Ishida Y, Yanaga K.

Anticancer Res. 2017 Jun;37(6):3207-3213.

PMID:
28551666
5.

Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.

Zhao J, van Mierlo KMC, Gómez-Ramírez J, Kim H, Pilgrim CHC, Pessaux P, Rensen SS, van der Stok EP, Schaap FG, Soubrane O, Takamoto T, Viganò L, Winkens B, Dejong CHC, Olde Damink SWM; Chemotherapy-Associated Liver Injury (CALI) consortium.

Br J Surg. 2017 Jul;104(8):990-1002. doi: 10.1002/bjs.10572. Epub 2017 May 25. Review.

PMID:
28542731
6.

[Portal vein embolization: Present and future].

Piron L, Deshayes E, Escal L, Souche R, Herrero A, Pierredon-Foulongne MA, Assenat E, le Lam N, Quenet F, Guiu B.

Bull Cancer. 2017 May;104(5):407-416. doi: 10.1016/j.bulcan.2017.03.009. Epub 2017 May 3. Review. French.

PMID:
28477870
7.

Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma.

Tang H, Lu W, Yang Z, Jiang K, Chen Y, Lu S, Dong J.

Medicine (Baltimore). 2017 Apr;96(17):e6795. doi: 10.1097/MD.0000000000006795.

8.

[A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].

Sato K, Akiyama H, Kogure Y, Suwa Y, Momiyama M, Ishibe A, Endo I.

Gan To Kagaku Ryoho. 2017 Apr;44(4):329-331. Review. Japanese.

PMID:
28428515
9.

Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma.

Cho Y, Kim TH, Seong J.

Strahlenther Onkol. 2017 Aug;193(8):620-629. doi: 10.1007/s00066-017-1128-7. Epub 2017 Apr 19.

PMID:
28424838
10.

Thymoma metastatic to liver and pancreas: case report and review of the literature.

Passuello N, Pozza G, Blandamura S, Valmasoni M, Sperti C.

J Int Med Res. 2017 Apr;45(2):868-874. doi: 10.1177/0300060516680673. Epub 2017 Feb 13.

PMID:
28415940
11.

Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients.

Adam R, Yi B, Innominato PF, Barroso E, Laurent C, Giuliante F, Capussotti L, Lapointe R, Regimbeau JM, Lopez-Ben S, Isoniemi H, Hubert C, Lin JK, Gruenberger T, Elias D, Skipenko OG, Guglielmi A; LiverMetSurvey International Contributing Centers.

Eur J Cancer. 2017 Jun;78:7-15. doi: 10.1016/j.ejca.2017.03.009. Epub 2017 Apr 10.

PMID:
28407529
12.

Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter.

Zhong JH, Pan LH, Wang YY, Cucchetti A, Yang T, You XM, Ma L, Gong WF, Xiang BD, Peng NF, Wu FX, Li LQ.

Medicine (Baltimore). 2017 Apr;96(15):e6608. doi: 10.1097/MD.0000000000006608.

13.

Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre.

Norero E, Vega EA, Diaz C, Cavada G, Ceroni M, Martínez C, Briceño E, Araos F, Gonzalez P, Baez S, Vinuela E, Caracci M, Diaz A.

Eur J Surg Oncol. 2017 Jul;43(7):1330-1336. doi: 10.1016/j.ejso.2017.01.004. Epub 2017 Feb 10.

PMID:
28359594
14.

Laparoscopic and Open Splenectomy and Hepatectomy.

Li JF, Bai DS, Jiang GQ, Chen P, Jin SJ, Zhu ZX.

JSLS. 2017 Jan-Mar;21(1). pii: e2016.000104. doi: 10.4293/JSLS.2016.000104.

15.

Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review).

Al Bandar MH, Kim NK.

Oncol Rep. 2017 May;37(5):2553-2564. doi: 10.3892/or.2017.5531. Epub 2017 Mar 27. Review.

PMID:
28350137
16.

From Detection to Resection: Photoacoustic Tomography and Surgery Guidance with Indocyanine Green Loaded Gold Nanorod@liposome Core-Shell Nanoparticles in Liver Cancer.

Guan T, Shang W, Li H, Yang X, Fang C, Tian J, Wang K.

Bioconjug Chem. 2017 Apr 19;28(4):1221-1228. doi: 10.1021/acs.bioconjchem.7b00065. Epub 2017 Apr 11.

PMID:
28345887
17.

Liver Transplantation for Polycystic Liver Disease Due to Huge Liver With Related Complications: A Case Report.

Acar S, Gencdal G, Tokac M, Eren E, Alkara U, Tellioglu G, Dinckan A, Akyildiz M.

Transplant Proc. 2017 Apr;49(3):603-605. doi: 10.1016/j.transproceed.2017.01.033.

PMID:
28340841
18.

Surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma for various resection extent.

Chen J, Li H, Liu F, Li B, Wei Y.

Medicine (Baltimore). 2017 Mar;96(12):e6460. doi: 10.1097/MD.0000000000006460.

19.

Retroperitoneal and intrahepatic metastasis from primary clear cell carcinoma of the liver: A case report and review of the literature.

Xiong J, He D, Hu W, Liu X.

Medicine (Baltimore). 2017 Mar;96(12):e6452. doi: 10.1097/MD.0000000000006452.

20.

Survival outcomes of hepatocellular carcinoma resection with postoperative complications - a propensity-score-matched analysis.

Chok KS, Chan MM, Dai WC, Chan AC, Cheung TT, Wong TC, She WH, Lo CM.

Medicine (Baltimore). 2017 Mar;96(12):e6430. doi: 10.1097/MD.0000000000006430.

Supplemental Content

Loading ...
Support Center